StonvexLoading…
StonvexStonvexStonvexCore line items from GGG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-27 | Annual 2025 2025-12-26 | Q3 2025 2025-09-26 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $540.14M | $2.24B | $1.64B | $1.10B |
Operating Income | $137.78M | $624.80M | $466.22M | $301.50M |
Net Income | $118.51M | $521.84M | $389.35M | $251.72M |
EPS (Diluted) | $0.70 | $3.08 | $2.30 | $1.48 |
Total Assets | $3.33B | $3.27B | $3.23B | $3.05B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $712.17M | $624.08M | $618.66M | $534.92M |
Free Cash Flow OCF − CapEx | $108.11M | $637.92M | $453.62M | $277.92M |
Shares Outstanding | 168.33M | 165.15M | 169.59M | 170.07M |